Ehsan Shandiz

Dr. Ehsan Shandiz


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in Clinical Neurophysiology
Verified
Journal Article
Closed access
ESEhsan Shandiz
Ehsan Shandiz
AGAsbjorn Gaskell
Asbjorn Gaskell
MIMatthew Ingram
Matthew Ingram
GTGabriel S. Trajano
Gabriel S. Trajano
GFGabriel Lima Fernandes
Gabriel Lima Fernandes
RHRobert David Henderson
Robert David Henderson

21 September 2023 in Clinical Case Reports
Verified
Journal Article
Open access
ANAndrew Dang Khai Nguyen
Andrew Dang Khai Nguyen
RSRonald Siu
Ronald Siu
GKGrant Kleinschmidt
Grant Kleinschmidt
BSBimal Prakash Sood
Bimal Prakash Sood
ESEhsan Shandiz
Ehsan Shandiz
Key Clinical Message: Consider the differential of Epstein–Barr virus (EBV) reactivation in pregnant women who develop progressive meningoencephalitis and transverse myelitis. EBV nucleic acid amplification should be considered in immunosuppressed patients. A 32‐year‐old G10P6M3K22 pregnant female presented to a regional hospital with progressive severe neurological and behavioral deficits. Magnetic resonance revealed cervical transverse myelitis. Lumbar puncture confirmed Epstein–Barr virus (EBV) DNA on a background of IgG‐positive EBV serology. A diagnosis of EBV reactivation‐related meningoencephalitis with transverse myelitis in pregnancy was concluded.

24 October 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ESEhsan Shandiz
Ehsan Shandiz
GFGabriel Lima Fernandes
Gabriel Lima Fernandes
JHJoao Saldanha Henkin
Joao Saldanha Henkin
PMPamela Ann McCombe
Pamela Ann McCombe
GTGabriel Siqueira Trajano
Gabriel Siqueira Trajano
RHRobert David Henderson
Robert David Henderson
Background. This study aims to determine if Riluzole usage can change the function and excitability of motor neurons. Methods. The clinical data and indices of motor neuron excitability were assessed using high-density surface EMG parameters from 80 ALS participants. The persistent inward current was assessed using the discharge rate from paired motor units obtained from the tibialis anterior muscle. This enabled the discharge rate at recruitment, peak discharge rates and the hysteresis of the recruitment–derecruitment frequencies (also known as delta F) to be calculated. Limbs were classified according to their strength. Results. No differences in these motor neuron discharge properties were found according to whether Riluzole was used. Conclusions. The possible interpretations of this finding are discussed.

8 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
DYDennis Yeow
Dennis Yeow
ARAndre Lm Reis
Andre Lm Reis
ISIgor Stevanovski
Igor Stevanovski
NNNeysa Njo
Neysa Njo
LRLaura Ivete Rudaks
Laura Ivete Rudaks
IDIra W Deveson
Ira W Deveson
Inherited myopathies are a group of disorders with diverse and complex genetic aetiologies. The causative genetic variants vary widely in type, size and sequence context, encompassing small sequence variants and large structural variants in protein-coding genes, mitochondrial variants, repeat expansions, and more complex events, such as the chromosome 4 D4Z4 macrosatellite contraction and hypomethylation that causes facioscapulohumeral muscular dystrophy (FSHD). This poses a challenge for analysis with next generation sequencing and other molecular methods. This is further compounded by phenotypic variability between patients and phenotypic overlap of different forms of genetic myopathy. To accelerate myopathy research and improve diagnosis we have developed a targeted long-read sequencing assay and an integrated bioinformatics analysis framework that captures the full suite of genes, variants and epigenetic signatures currently implicated in all forms of inherited myopathy. Applying this to a cohort of 53 myopathy patients with and without previous genetic diagnoses, we demonstrate the analytical validity of our approach, as well as its improved accuracy and resolution compared to existing methods - especially for FSHD. Our LRS assay identified an array of new information about the genetic and epigenetic landscape of inherited myopathies and provided new diagnoses for 29% of patients who had remained undiagnosed following clinical genetic testing. In our cohort, FSHD and oculopharyngodistal myopathies were the most common new diagnoses that were missed or mis-diagnosed by standard clinical genetic testing. Our new method constitutes a single streamlined assay for comprehensive genetic and epigenetic characterisation of inherited myopathies.

19 February 2026 in Clinical Neurophysiology
Verified
Journal Article
Open access
GFGabriel Lima Fernandes
Gabriel Lima Fernandes
LOLucas B.R. Orssatto
Lucas B.R. Orssatto
MPMatheus Daros Pinto
Matheus Daros Pinto
JHJoao S. Henkin
Joao S. Henkin
ESEhsan Shandiz
Ehsan Shandiz
GTGabriel S. Trajano
Gabriel S. Trajano
Amyotrophic lateral sclerosis (ALS) is characterised by progressive degeneration of upper and lower motor neurons and their motor units (MUs). MU loss is compensated by collateral sprouting and reinnervation of muscle fibres. There is limited information about the properties of these surviving MUs as these processes take place. High-density surface electromyography (HD-sEMG) decomposition enables non-invasive analysis of individual MU firing behaviour during maximal voluntary contractions and assess their changes with ALS progression. Thirty-nine individuals with ALS (24 men; mean age 63 ± 16 years) completed up to five visits (interval 20.0 ± 7.9 weeks). Tibialis anterior HD-sEMG recordings during maximal contractions were decomposed into individual MU spike trains, from which maximal firing rates were quantified. Muscle strength was assessed with the Medical Research Council (MRC) scale, and global function with the revised ALS Functional Rating Scale (ALSFRS-R). Maximal MU firing rates declined significantly over time [-0.32 Hz/month, (95% CI -0.44; -0.19)], regardless of MRC scores. Across participants, maximal firing rates decreased by 2.38 Hz (1.78; 2.98) for each 1-point reduction in MRC and by 0.54 Hz for each ALSFRS-R point (-0.83; -0.26). These findings demonstrate that maximal MU firing rates decline as ALS progresses, suggesting that the surviving motor unit undergo progressive pathophysiological changes as motor neurons degenerate. HD-sEMG MU firing-rates analysis appeared more sensitive than MRC in detecting early deterioration in muscle decline. Maximal firing rates analysis has the potential to serve as a quantitative clinical biomarker of neuromotor system degeneration, complementing global functional scales in clinical monitoring.